Drug Database
Back to search

Poland· PL-100472485

Lynagex XR

A pregabalin product containing pregabalinum, registered in Poland by Exeltis Poland Sp. z o.o.. The same ATC class is registered in 3 of our 19 countries.

ATC N03AX16

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedLynagex XRATCN03AX16REGISTER NO.PL-100472485PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about pregabalinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Pregabalin is registered in 3 of 19 countries.

Countries holding a registration under ATC N03AX16 (pregabalin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose
Search pregabalin products by name

Pregabalin · ATC N03AX16

3 / 19 countries

  • Belgiumprice
  • Ireland
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Pregabalinum
Manufacturer
Exeltis Poland Sp. z o.o.
Country
Poland (PL)
ATC code
N03AX16
ATC class
Pregabalin
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991552916
  • gtin
    05908445453007

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

282 interactions on record for pregabalin.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check pregabalin against other medicinesHow interaction checks work

Pregabalin · interactions on record

282 records

  • 4 severe
  • 60 moderate
  • 180 info

Most severe, free to view

  • MorphineN02AA01severe
  • MorphinN07BC09severe
  • HydrocodoneR05DA03severe
  • CodeineR05DA04severe

38 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pregabalin in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pregabalin products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Lynagex, Lynagex 165 Mg
  • Belgium · Lynagex, Pregabalin Ab
  • Bulgaria · Pregabin, Бриека
  • Cyprus · Epibal, Grabilen
  • Czechia · Kartesada, Naxalgan
  • Germany · Pregabador, Pregabahexal
  • Denmark · Galberin, Lyribastad
  • Estonia · Brieka, Bulgaplin
  • Spain · Aciryl, Apregia
  • Finland · Lyribastad, Pregabalin Grindeks
  • France · Lexenu, Lexenu 75 Mg
  • United Kingdom (Northern Ireland) · Alzain, Avellar
  • Greece · Algecia, Apregalin
  • Croatia · Pragiola, Pregabalin Belupo
  • Hungary · Kartesada, Naxalgan
  • Ireland · Pregabalin Basics, Pregabalin Brillpharma (Ireland)
  • Iceland · Brieka, Lyrica
  • Italy · Aclaton, Ecubalin
  • Liechtenstein · Lyrica, Pregabalin Accord
  • Lithuania · Brieka, Bulgaplin
  • Luxembourg · Pregabalin Micro Labs, Pregabaline Eg
  • Latvia · Brieka, Bulgaplin
  • Malta · Epibal, Pragiola
  • Netherlands · Dalingo, Linefor
  • Norway · Lyrica, Pregabalin 1a Farma
  • Portugal · Kartesada, Lygabrin
  • Romania · Lynagex, Pragiola
  • Sweden · Brieka, Bulgaplin
  • Slovenia · Pragiola, Pregabalin Grindeks
  • Slovakia · Kartesada, Naxalgan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d6f5a518-c14a-478b-96f6-d2f97f37be50
GET /v1/drugs/d6f5a518-c14a-478b-96f6-d2f97f37be50?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki o przedłużonym uwalnianiu",
  "source": "urpl",
  "strength": "82,5 mg",
  "packaging": "05909991552916 ¦ Rp ¦ 157667\n30 tabl. w pojemniku\n05908445453007 ¦ Rp ¦ 164554\n30 tabl. w blistrze",
  "substance": "Pregabalinum 82.5 mg",
  "common_name": "Pregabalinum",
  "pl_product_id": "100472485",
  "pozwolenie_nr": "28559",
  "auth_procedure": "DCP",
  "authorisation_validity": "2029-08-12"
}
API referenceMCP serverPlans

See everything about pregabalin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console